Posted by Sten Westgard, MS
posted by Sten Westgard, MS
The Unacceptable IssueThis issue of the Westgard Newsletter is devoted to exploring the rejections, the abnormals, the outliers - in other words, the Unacceptable performance and practices of the laboratory.At the LabQuality Conference in Helsinki, Mark Thelen of SKML made a very trenchant observation: We should not punish laboratories for the failures of the manufacturers. Analytical performance specifications derived from biological variation studies, both old and new, may be too demanding for today's methods.We may use these new biological variation-derived goals to determine when the laboratory is performing unacceptably. But if no labs and no methods are able to achieve this goal, then perhaps we need to realize the manufacturers are the ones performing unacceptably - by failing to engineer methods good enough to meet the necessary goals.We often see conferences, workshops, and meetings that proclaim the reinvention of Quality Control, the revolution, the next-generation, the "2.0" of QC. But more importantly, we may need to redefine what is UNacceptable for today's laboratories.How LabQuality Days tackled the subject of reinventing QCAre today's hemostasis METHODS unacceptable? Or are today's GOALS for hemostasis goals unattainable?
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
Posted by Sten Westgard, MS
An opportunity to demonstrate your patient impact! If we face the reality that the laboratory future must involve a closer interaction with clinical care and outcomes, here's an award that focuses on that very thing. Demonstrate how your lab results improve care and benefit patients, and your healthcare organization will receive and award from a consortium of AACC, IFCC, HIMSS, Modern Healthcare and more: https://lnkd.in/dGBz5Fq hashtag#Univants hashtag#labfuture
[full disclosure: this award is sponsored in part by Abbott Diagnostics, a company with which Westgard QC has business.]
-----